21 CFR Part 11 Compliance Consultant for UAE
Navigate FDA electronic records and electronic signatures requirements with expert guidance. We help pharmaceutical, biotech, and medical device companies achieve and maintain 21 CFR Part 11 compliance across all regulated systems.
20+
Years FDA Experience
100%
Inspection Success
2-6
Month Remediation
ALCOA+
Data Integrity Aligned
Our Part 11 Consulting Services
From initial assessment through remediation and ongoing compliance, we provide comprehensive 21 CFR Part 11 support for FDA-regulated industries.
Part 11 Gap Assessments
Comprehensive evaluation of your systems against 21 CFR Part 11 requirements, identifying compliance gaps and prioritizing remediation activities based on risk.
Remediation Planning & Execution
Prioritized remediation roadmaps with clear timelines, resource requirements, and implementation support to close identified compliance gaps.
Electronic Signature Implementation
Compliant e-signature workflows with proper manifestation, linking to electronic records, and validation of signature meaning and intent.
Audit Trail Configuration
System configuration ensuring complete, immutable audit trails that capture who, what, when, and why for all electronic record modifications.
System Access Controls
Role-based access control design, user authentication configuration, and security procedures including password policies and session management.
Ongoing Compliance Monitoring
Periodic assessments, change control support, and continuous compliance maintenance to sustain Part 11 validated state.
Data Integrity & ALCOA+
Alignment with ALCOA+ principles ensuring electronic records are Attributable, Legible, Contemporaneous, Original, and Accurate with complete traceability.
SOP & Documentation Development
Development of Standard Operating Procedures for electronic records management, audit trail review, e-signature usage, and system access controls.
Our Part 11 Compliance Methodology
A systematic six-phase approach to achieving and maintaining 21 CFR Part 11 compliance that minimizes disruption while ensuring thorough regulatory alignment.
Current State Assessment
We conduct a thorough gap analysis of your existing systems against 21 CFR Part 11 requirements. This includes reviewing system configurations, existing SOPs, user access controls, audit trail capabilities, and electronic signature implementations to identify areas of non-compliance.
Risk Assessment & Prioritization
Not all gaps carry equal regulatory risk. We categorize identified gaps by severity and potential impact on data integrity and patient safety, creating a prioritized remediation plan that addresses critical issues first while managing resources effectively.
Technical Remediation
Implementation of technical controls including audit trail configuration, access control setup, electronic signature workflows, and system security hardening. We work with your IT team and vendors to configure systems for Part 11 compliance.
Procedural Controls
Development and implementation of SOPs covering electronic records management, audit trail review procedures, e-signature usage policies, user account management, and incident response. Training programs ensure staff understand their compliance responsibilities.
Validation & Documentation
Formal validation of Part 11 controls through IQ/OQ/PQ protocols. Creation of comprehensive compliance documentation including system security plans, validation summary reports, and traceability matrices demonstrating regulatory alignment.
Ongoing Compliance Maintenance
Establishing periodic review schedules, change control procedures, and continuous monitoring processes to maintain the validated state. Regular assessments ensure sustained compliance as regulations and systems evolve.
21 CFR Part 11 Key Requirements
Understanding the core requirements is essential for compliance. Part 11 establishes criteria across electronic signatures, audit trails, access controls, and operational procedures.
Electronic Signature Controls
- Unique user identification for each signer
- Signature manifestation (printed name, date/time, meaning)
- Signatures linked to respective electronic records
- Non-repudiation of signed records
Audit Trail Requirements
- Computer-generated, time-stamped audit trails
- Record creation, modification, and deletion tracking
- Secure, computer-generated audit trail entries
- Audit trails retained for required record retention period
System Access Controls
- Authority checks for system operations
- Device checks for terminal identification
- Procedures for handling lost/stolen tokens
- Controls for unauthorized use detection
Operational Controls
- Procedures for system access distribution
- Written policies for electronic signature accountability
- Controls for ensuring record authenticity
- Secure record retrieval throughout retention period
Systems Requiring Part 11 Compliance
Any computerized system that creates, modifies, maintains, or transmits electronic records subject to FDA predicate rules requires Part 11 compliance.
Frequently Asked Questions About 21 CFR Part 11
Expert answers to common questions about FDA electronic records and electronic signatures compliance.
Understanding 21 CFR Part 11 Compliance
21 CFR Part 11 is the FDA regulation that establishes criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. For pharmaceutical, biotech, and medical device companies operating in or exporting to the United States, Part 11 compliance is not optional—it's a regulatory requirement that can impact product approvals and market access.
The regulation applies to any electronic record created, modified, maintained, archived, retrieved, or transmitted under FDA predicate rules. This includes laboratory data, manufacturing batch records, quality management documentation, clinical trial data, and regulatory submissions. In today's digital environment, virtually every FDA-regulated company has systems that fall under Part 11 scope.
For UAE and GCC pharmaceutical companies exporting to the U.S. market or conducting FDA-regulated clinical trials, Part 11 compliance is essential. Our consulting services help you navigate these requirements efficiently, implementing practical controls that satisfy regulators without overburdening your operations. We combine deep regulatory knowledge with hands-on technical expertise to deliver compliance solutions that work.
Ready to Achieve Compliance Excellence?
Whether you're facing an audit, implementing new systems, or building AI solutions for regulated environments—we're here to help.
Free initial consultation • No obligation • UAE & GCC focused